The mouse and cell-culture data strongly suggest a loss of naturally occurring inhibitory activity of the Gln LOX-PP variant compared to wildtype Arg LOX-PP which ultimately results in the elevation of LOX production and tumor development (Figure 10). The gene discussed is LOX; the disease is neoplasm.